from the 10k
We have received an audit report that includes an explanatory paragraph stating that our recurring losses from operations raise substantial doubt about our ability to continue as a going concern on our fiscal 2012 consolidated financial statements.
The continuation of our Company as a going concern is dependent upon our attaining and maintaining profitable operations and/or raising additional capital. Our independent registered public accounting firm included, in their audit report on our consolidated financial statements for the year ended June 30, 2012, an explanatory paragraph regarding the substantial doubt about our ability to continue as a going concern. Our consolidated financial statements contain additional note disclosures describing our liquidity. As a result of this uncertainty, we may have a more difficult time obtaining necessary financing.
tick tock i smell a turd about to come to market
"we're booking revenues and raising our cost estimates, sorry guys no profits to be had and the bank owns all our assets with out 15% interest rate debt"
Sentiment: Strong Sell
UniLife's 9 lives are coming due real soon
no more bullets left for shortall and company
no more capital can he raise. he can't even name his unnamed financing provider
Sentiment: Strong Sell
shortall and company going to sadly disappoint...yet again
his affiliates getting ready to dump major shareholdings on your all
Just look at Uni-Pixel....tick tock tick tock
Uni-Life going to die very very soon...you all been warned
Sentiment: Strong Sell
$7m at 3/31/13 burning at rapid rate of at least $2.5m per month
...but don't worry all will be solved by a contract "to book revenue" immediately
followed by a 15% interest rate coupon
watch out below
Where do you think UNIS' money goes...
sucked into Shortall's pocket
he drives around in a Bentley on shareholders dime
pretty good for a guy who is delivered nothing ever in profits
Retractable Technologies (RVP)
oh yeah sorry they have revenue (UNIS does not) and look at the market cap $38m (UNIS $300m)
suckers are you gettitng the point yet?
he's paid himself lavishly for producing nothing
it's a typical ponzi scheme
when you're desperate you start doing even more criminal things to survive
just read the press releases
"unnamed financing provider"
what other companies do you know put out such garbage?
the answer is none of them
Shortall and UNIS are great at creating speculation
bad and making money
they lose shareholder money
and pocked it
that's their game
you need to find more buyers
more gullible believers
to keep the price up
but UNIS is out of bullets
after years of promises with nothing
this is their final bullet
but it's not coming
just more losses
they cannot make the product at a profit
there will be no bid on the way down
"Big news" comes with stock at an alll time low
they got no cash left
debt coming at 15%
mortgage all the assets IP etc
no proven ability to produce anything at a profit.
Good luck to ya'll
back at a 52 wk low very soon
this won't end well
just a matter of time
they have 0 visibility
suspended guidance and the stock goes up.....really???
longs here going to get hurt badly
read the annual report
UNIS is forever tied to 1 company
good luck getting other big pharam companies on board
The Unifill syringe has been designed to be compatible with the drug manufacturing systems currently utilized by Sanofi, which may hinder our ability to sell the product to other pharmaceutical customers whose manufacturing processes may not be compatible with our current product designs.
The Unifill syringe has been designed to be compatible with the drug filling and packaging systems of Sanofi. To our knowledge, the majority of fill-finish lines are designed and operated in a similar way. However, while the standard glass barrels to be used for the Unifill syringe are also currently utilized by most pharmaceutical companies, the specific processes used by other pharmaceutical companies to fill, manufacture or package prefilled syringes with an injectable drug product may vary from those of Sanofi. Furthermore, pharmaceutical companies may in some cases require the use of materials which are biocompatible with a particular drug compound and to which we do not have access. Such events may require design, material or process changes to our product, or restrict our ability to enter into supply relationships with other pharmaceutical companies and accordingly, may have a material adverse effect on our results of operations and financial condition.
just don't do large multiyear deals with shaky companies like UNIS
UNIS has 1qtr of cash left
you tell me what company would take the credit/operational risk of doing business with UNIS
UNIS has proven they can do nothing but burn cash